CRISPR,NatBα-synuclein

Saranya Santhosh Kumar1,2, Nima N Naseri2,3, Sarshan R Pather2,4

  • 1Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA, USA.

Science advances
|February 9, 2024
PubMed
概括

研究人员确定了α-synuclein (αSyn) 蛋白的关键调节者,这对帕金森病至关重要. 通过NatB酶向氨基末端乙化提供了一种潜在的治疗策略,以降低αSyn水平.